182 related articles for article (PubMed ID: 19785801)
1. [Lower costs for anticancer drugs by safety margin around calculated dose and by fine-tuning on ampoule strength].
Mertens S; de Jongh FE
Ned Tijdschr Geneeskd; 2009; 153():B162. PubMed ID: 19785801
[TBL] [Abstract][Full Text] [Related]
2. [Rising costs of drugs in hospitals in the period 1996-2000 and over the next few years].
Breekveldt-Postma NS; Zwart-van Rijkom JE; Egberts AC; Leufkens HG; Herings RM
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2547-51. PubMed ID: 12532669
[TBL] [Abstract][Full Text] [Related]
3. Cost savings from dose rounding of biologic anticancer agents in adults.
Winger BJ; Clements EA; DeYoung JL; O'Rourke TJ; Claypool DL; Vachon S; VanDyke TH; Zimmer-Young J; Kintzel PE
J Oncol Pharm Pract; 2011 Sep; 17(3):246-51. PubMed ID: 20332175
[TBL] [Abstract][Full Text] [Related]
4. [To which criterion should the dosage of anticancer drug be adapted?].
Desoize B
Bull Cancer; 1993 May; 80(5):376-90. PubMed ID: 8173191
[TBL] [Abstract][Full Text] [Related]
5. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package.
Kleinberg ML; Duafala ME
Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222
[TBL] [Abstract][Full Text] [Related]
6. Cost avoidance from dose rounding biologic and cytotoxic antineoplastics.
Vandyke TH; Athmann PW; Ballmer CM; Kintzel PE
J Oncol Pharm Pract; 2017 Jul; 23(5):379-383. PubMed ID: 27000279
[TBL] [Abstract][Full Text] [Related]
7. Implications of dose rounding of chemotherapy to the nearest vial size.
Dooley MJ; Singh S; Michael M
Support Care Cancer; 2004 Sep; 12(9):653-6. PubMed ID: 14986078
[TBL] [Abstract][Full Text] [Related]
8. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness analysis of 5-HT3 receptor antagonist drugs in cancer chemotherapy].
Ishimaru H; Takayama S; Shiokawa M; Inoue T
Gan To Kagaku Ryoho; 2008 Apr; 35(4):619-23. PubMed ID: 18408430
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of fixed dosing of new anticancer agents in phase I studies.
Levêque D
Anticancer Res; 2008; 28(5B):3075-7. PubMed ID: 19031959
[TBL] [Abstract][Full Text] [Related]
11. Body surface area estimation in children using weight alone: application in paediatric oncology.
Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
[TBL] [Abstract][Full Text] [Related]
12. [Cost of medications in the oncology sector in the context of health economics].
Walter E; Batista A
Wien Med Wochenschr; 2008; 158(7-8):227-33. PubMed ID: 18500477
[TBL] [Abstract][Full Text] [Related]
13. [Impact of the chemotherapy protocols for metastatic breast cancer on the treatment cost and the survival time of 371 patients treated in three hospitals of the Rhone-Alpes region].
Paviot BT; Bachelot T; Clavreul G; Jacquin JP; Mille D; Rodrigues JM
Bull Cancer; 2009 Oct; 96(10):929-40. PubMed ID: 19696006
[TBL] [Abstract][Full Text] [Related]
14. Body surface area for adjustment of drug dose.
Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
[TBL] [Abstract][Full Text] [Related]
15. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
[TBL] [Abstract][Full Text] [Related]
16. Rounding rituximab dose to nearest vial size.
Patel S; Le A
J Oncol Pharm Pract; 2013 Sep; 19(3):218-21. PubMed ID: 23114093
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the potential impact of dose rounding parenteral chemotherapy agents on cost savings and drug waste minimization.
Chillari KA; Southward J; Harrigan N
J Oncol Pharm Pract; 2018 Oct; 24(7):507-510. PubMed ID: 28732452
[TBL] [Abstract][Full Text] [Related]
18. Loading doses for costly cancer biologicals: sound pharmacology or unnecessary extravagance?
Epstein RJ; Cheung BM
Eur J Cancer; 2008 Jul; 44(11):1488-92. PubMed ID: 18194858
[TBL] [Abstract][Full Text] [Related]
19. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center.
Chan A; Leow YC; Sim MH
J Oncol Pharm Pract; 2009 Sep; 15(3):161-5. PubMed ID: 19171555
[TBL] [Abstract][Full Text] [Related]
20. Potential cost savings by dose down-rounding of monoclonal antibodies in a community cancer center.
Copur MS; Gnewuch C; Schriner M; Tharnish M; Gonen M; McDonald M; Kezeor J; Ramaekers RC; Gauchan D; Clark D; Greenwalt L; Mickey M; Norvell M
J Oncol Pharm Pract; 2018 Mar; 24(2):116-120. PubMed ID: 29284380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
